Smartlab Europe

News

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to test a novel ImplaVax enabled pandemic flu vaccine. ImplaVax-enabled vaccination products leverage Enesi's innovative unit solid-dose,...

Silence and Hansoh partner to develop siRNA-based treatments

Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi GOLD platform. Following the conclusion of the Phase I clinical trial, Hansoh will hold an exclusive...

Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration

Antios Therapeutics, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment in patients with chronic hepatitis B virus (HBV) infection. A single cohort in the ongoing...

Moleculin obtains UK MHRA authorisation for Phase Ia trial of Covid-19 drug

Moleculin Biotech has obtained the UK Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation to initiate a Phase Ia clinical trial of its drug, WP1122, in the country to treat Covid-19. An inhibitor of metabolism/glycosylation, WP1122 is a prodrug of...

Stevanato Group Wins Pharma Innovation Award For AI-ready Vision Robot Unit (VRU)

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has been recognized as a winner of Pharma Manufacturing magazine’s 2021 Pharma Innovation Award for its AI-ready Vision...

Aptar CSP Technologies Awarded $19 Million Contract to Expand Production Capacity for its Active Film Technology

Aptar CSP Technologies, part of AptarGroup, Inc., and a leader in active material science solutions that ensure product protection, extend shelf life and improve user experience, was awarded a $19 million contract from the U.S. government. This award will...

West Introduces DeltaCube Modeling Platform and NovaGuard SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will unveil its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »